Related references
Note: Only part of the references are listed.Differences in the Presentation and Progression of Parkinson's Disease by Sex
Hirotaka Iwaki et al.
MOVEMENT DISORDERS (2021)
Istradefylline - a first generation adenosine A2A antagonist for the treatment of Parkinson's disease
Peter Jenner et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2021)
Influence of istradefylline on non-motor symptoms of Parkinson's disease: A subanalysis of a 1-year observational study in Japan (J-FIRST)
Yasushi Shimo et al.
PARKINSONISM & RELATED DISORDERS (2021)
Apathy and Anxiety in De Novo Parkinson's Disease Predict the Severity of Motor Complications
Jared T. Hinkle et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2021)
Diagnosis and Treatment of Parkinson Disease A Review
Melissa J. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Sex differences in movement disorders
Sara Meoni et al.
NATURE REVIEWS NEUROLOGY (2020)
Non-motor symptom burden is strongly correlated to motor complications in patients with Parkinson's disease
D. Santos-Garcia et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Rapid drug increase and early onset of levodopa-induced dyskinesia in Parkinson's disease
Jin Yong Hong et al.
PLOS ONE (2020)
Zonisamide for the Treatment of Parkinson Disease: A Current Update
Chengqian Li et al.
FRONTIERS IN NEUROSCIENCE (2020)
Istradefylline to Treat Patients with Parkinson's Disease Experiencing Off Episodes: A Comprehensive Review
Amnon A. Berger et al.
NEUROLOGY INTERNATIONAL (2020)
Real-World Nonmotor Changes in Patients with Parkinson's Disease and Motor Fluctuations: J-FIRST
Hirohisa Watanabe et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2020)
Levodopa-induced dyskinesia is closely linked to progression of frontal dysfunction in PD
Han Soo Yoo et al.
NEUROLOGY (2019)
Continuous subcutaneous apomorphine infusion in Parkinson's disease: causes of discontinuation and subsequent treatment strategies
Enrica Olivola et al.
NEUROLOGICAL SCIENCES (2019)
Predictors of motor complications in early Parkinson's disease: A prospective cohort study
Mark J. Kelly et al.
MOVEMENT DISORDERS (2019)
Age and time course of long-term motor and nonmotor complications in Parkinson disease
Stephane Prange et al.
NEUROLOGY (2019)
Long-term treatment of Parkinson's disease with levodopa and other adjunctive drugs
Yoshikuni Mizuno et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease
Carla Masala et al.
JOURNAL OF NEUROLOGY (2018)
Risk factors for non-motor symptoms in Parkinson's disease
Johan Marinus et al.
LANCET NEUROLOGY (2018)
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts
Alberto J. Espay et al.
ANNALS OF NEUROLOGY (2018)
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort
Paolo Eusebi et al.
NPJ PARKINSONS DISEASE (2018)
The relevance of gender in Parkinson's disease: a review
Marina Picillo et al.
JOURNAL OF NEUROLOGY (2017)
Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease
Roberta Balestrino et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Impulse Control Disorders in Advanced Parkinson's Disease With Dyskinesia: The ALTHEA Study
Roberta Biundo et al.
MOVEMENT DISORDERS (2017)
Clinical manifestations of nonmotor symptoms in 1021 Japanese Parkinson's disease patients from 35 medical centers
Tetsuya Maeda et al.
PARKINSONISM & RELATED DISORDERS (2017)
Motor Complications of Dopaminergic Medications in Parkinson's Disease
Maria Eliza Freitas et al.
SEMINARS IN NEUROLOGY (2017)
Parkinson Disease: The Relationship Between Non-motor Symptoms and Motor Phenotype
Fang Ba et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2016)
The impact of non-motor symptoms on the quality of life of Parkinson's disease patients: a longitudinal study
K. M. Prakash et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Zonisamide Improves Wearing- Off in Parkinson's Disease: A Randomized, Double- Blind Study
Miho Murata et al.
MOVEMENT DISORDERS (2015)
Action tremor in Parkinson's disease: frequency and relationship to motor and non-motor signs
A. F. Gigante et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
Roberto Cilia et al.
BRAIN (2014)
Prescribing Pattern of Anti-Parkinson Drugs in Japan: A Trend Analysis from 2005 to 2010
Sachiko Nakaoka et al.
PLOS ONE (2014)
Presynaptic mechanisms of L-DOPA-induced dyskinesia: the findings, the debate, and the therapeutic implications
M. Angela Cenci
FRONTIERS IN NEUROLOGY (2014)
Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease
C. Warren Olanow et al.
MOVEMENT DISORDERS (2013)
Motor and non-motor symptoms of 1453 patients with Parkinson's disease: Prevalence and risks
Asako Yoritaka et al.
PARKINSONISM & RELATED DISORDERS (2013)
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life
Angelo Antonini et al.
JOURNAL OF NEUROLOGY (2012)
Levodopa-Induced-Dyskinesias Clinical Features, Incidence, Risk Factors, Management and Impact on Quality of Life
Alice Manson et al.
JOURNAL OF PARKINSONS DISEASE (2012)
Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation
Mahmoud M. Iravani et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
The natural history of treated Parkinson's disease in an incident, community based cohort
Jonathan R. Evans et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
The Impact of Levodopa on Quality of Life in Patients With Parkinson Disease
Kapil D. Sethi
NEUROLOGIST (2010)
ZONISAMIDE: A NEW DRUG FOR PARKINSON'S DISEASE
M. Murata
DRUGS OF TODAY (2010)
Zonisamide improves motor function in Parkinson disease - A randomized, double-blind study
Miho Murata et al.
NEUROLOGY (2007)
A hospital-based study:: Risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy
Gulcin Benbir et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2006)
Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs:: a prospective European study
M Péchevis et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Impact of the motor complications of Parkinson's disease on the quality of life
S Chapuis et al.
MOVEMENT DISORDERS (2005)
Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
JE Ahlskog et al.
MOVEMENT DISORDERS (2001)
Share Paper
